Skip to main content
OpenTrials

Clinical trial condition

Respiratory Syncytial Virus Infections

Explore clinical trials studying Respiratory Syncytial Virus Infections. Study availability and eligibility vary by location and protocol.

144 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Syncytial Virus Infections trial results

Completed

Safety and Immune Response to a Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

NCT02237209

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • Usc La Nichd Crs Alhambra, California, United States
  • University of California, UC San Diego CRS La Jolla, California, United States
  • Univ. of Colorado Denver NICHD CRS Aurora, Colorado, United States
  • Rush Univ. Cook County Hosp. Chicago NICHD CRS Chicago, Illinois, United States
View Trial Details
Completed

Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children

NCT00129766

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Alabama Neonatal Medicine OC Pike Road, Alabama, United States
  • Maricopa Medical Center Phoenix, Arizona, United States
  • Central Arkansas Pediatric Clinic, PA Benton, Arkansas, United States
View all 344 locations
View Trial Details
Completed

Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age

NCT01754428

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arkansas Children's Hospital/University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of Colorado Denver/Children's Hospital Colorado Denver, Colorado, United States
  • Pediatrics & Adolescent Medicine, P.A. Marietta, Georgia, United States
View all 15 locations
View Trial Details
Completed

Study of Motavizumab (MEDI-524) and Palivizumab Administered Sequentially in the Same Respiratory Syncytial Virus (RSV) Season

NCT00316264

Conditions
Chronic Lung Disease and <= 24 Months of Age or, Female Urogenital Diseases and Pregnancy Complications, Infections, +12 more
Locations
  • Department of Paediatrics and Child Health, The Canberra Hospital Garran, Australian Capital Territory, Australia
  • Neonatalogy John Hunter Hospital New Lambton Heights, New South Wales, Australia
  • Caboolture Clinical Research Caboolture, Queensland, Australia
  • University of Queensland, Royal Children's Hospital Herston, Queensland, Australia
View all 19 locations
View Trial Details
Completed

Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age

NCT00493285

Conditions
Infections, Mononegavirales Infections, Parainfluenza Virus 3, Human, +6 more
Locations
  • Arkansas Pediatric Research Division Conway, Arkansas, United States
  • Arkansas Pediatric Clinic Little Rock, Arkansas, United States
  • THe Children's Hospital Aurora, Colorado, United States
  • Miami Children's Hospital Miami, Florida, United States
View all 30 locations
View Trial Details

Related conditions